AItewan BioMedical Technology Inc.
↗Taipei, Taiwan
AItewan BioMedical Technology Inc. is a Taiwan-based medical technology company specializing in AI-driven software for medical imaging. The company focuses on developing intelligent precision medicine systems, particularly for brain tumor detection and analysis, to assist clinicians in radiation therapy planning and diagnostic workflows.
Founded as a spin-off from National Yang Ming Chiao Tung University (NYCU), the company leverages proprietary deep learning technology to provide automated segmentation and volumetric analysis of brain tumors from MRI scans. Their flagship product, DeepBT, is designed to integrate into clinical workflows to enhance diagnostic efficiency and accuracy.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
FUNDING
Stage:Pre-IPO
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (DeepBT Detector)
Modalities:AI Software (SaMD)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:National Yang Ming Chiao Tung University (NYCU) - Research and licensing, Taipei Veterans General Hospital - Licensing and clinical collaboration, Portwell - Hardware and integration partnership
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Wu Yu-Te - Co-founder
Guo Wan-Yuo - Co-founder
Scientific Founders:Wu Yu-Te, Guo Wan-Yuo
LINKS
Website:aitewan-bio.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of AItewan BioMedical Technology Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with AItewan BioMedical Technology Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.